Prognostic Impact of p 62 Expression in Cutaneous Malignant Melanoma
暂无分享,去创建一个
S. Horswell | N. Kirkham | J. Armstrong | P. Lovat | T. Ness | R. Ellis | J. Lumsdon | A. Sharon | Tooze
[1] K. Garber. Inducing indigestion: companies embrace autophagy inhibitors. , 2011, Journal of the National Cancer Institute.
[2] M. Komatsu,et al. Selective degradation of p62 by autophagy , 2010, Seminars in Immunopathology.
[3] S. Fulda,et al. Targeting X-linked inhibitor of apoptosis protein to increase the efficacy of endoplasmic reticulum stress-induced apoptosis for melanoma therapy. , 2010, The Journal of investigative dermatology.
[4] M. Komatsu,et al. Physiological significance of selective degradation of p62 by autophagy , 2010, FEBS letters.
[5] Jeffrey E Gershenwald,et al. Final version of 2009 AJCC melanoma staging and classification. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] Gyan Bhanot,et al. Autophagy Suppresses Tumorigenesis through Elimination of p62 , 2009, Cell.
[7] Masaaki Komatsu,et al. Homeostatic Levels of p62 Control Cytoplasmic Inclusion Body Formation in Autophagy-Deficient Mice , 2007, Cell.
[8] W. Sauerbrei,et al. REporting recommendations for tumor MARKer prognostic studies (REMARK) , 2006, Breast Cancer Research and Treatment.